Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AC053503.2 (ENSG00000232789) is a pseudogene annotated as similar to a portion of protein tyrosine phosphatase, receptor type, N (PTPRN)[1][2][3]. Pseudogenes are genomic DNA sequences similar to known genes but typically nonfunctional due to mutations or truncations, and they do not encode active proteins[5]. Thus, AC053503.2 does not produce an active receptor, enzyme, or transporter and has no known molecular function or disease roles. It is not considered a drug or biomarker target in therapeutic contexts. If your goal is to find structured information for protein drug targets, use the canonical active gene "Protein tyrosine phosphatase, receptor type, N" (PTPRN) instead[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AC053503.2 (pseudogene similar to protein tyrosine phosphatase, receptor type, N).